Cardiovascular Initiative of the Human Proteome Organisation, 5th Workshop October 2007, Seoul, Korea

Sarah Warburton1, Melanie Y White, Jennifer E Van Eyk

  • 1Department of Anesthesiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Proteomics
|February 2, 2008
PubMed

Insights

The Cardiovascular Initiative (CVI) of the Human Proteome Organisation (HUPO) held its fifth workshop. This report details the CVI

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Biomedical Research

Background:

  • The Human Proteome Organisation's Cardiovascular Initiative (CVI) convened its fifth workshop in Seoul, Korea, preceding the Sixth Annual HUPO World Congress in October 2007.
  • This event aimed to introduce the CVI's history and objectives to a broader scientific audience.
  • The workshop served as a platform to disseminate information about ongoing and future collaborative proteomic research in cardiovascular disease.

Framework:

  • The CVI operates as a collaborative framework within HUPO, focusing on proteomic research relevant to cardiovascular health and disease.
  • It aims to foster international cooperation and standardization in cardiovascular proteomics.
  • Key objectives include identifying and validating cardiovascular biomarkers and understanding disease mechanisms at the proteome level.

Implementation:

  • The workshop featured lectures by CVI members, highlighting key research areas and progress.
  • Discussions focused on the historical development and foundational principles of the CVI.
  • Current and prospective collaborative projects were presented to encourage community engagement and participation.

Implications:

  • Increased awareness of the CVI's mission and activities within the global scientific community.
  • Potential for enhanced collaboration and resource sharing in cardiovascular proteomics research.
  • Advancement of proteomic strategies for improved understanding, diagnosis, and treatment of cardiovascular diseases.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...